Nonradioactive Pharmaceuticals in Nuclear Medicine

Journal of Nuclear Medicine Technology

Hee-Myung Park¹  Kara Duncan¹ 

[1] Nuclear Medicine Division, Indiana University Medical Center, Indianapolis; and School of Pharmacy, Purdue University, West Lafayette, Indiana Nuclear Medicine Division, Indiana University Medical Center, Indianapolis; and School of Pharmacy, Purdue University, West Lafayette, Indiana Nuclear Medicine Division, Indiana University Medical Center, Indianapolis; and School of Pharmacy, Purdue University, West Lafayette, Indiana

关键词: acetazolamide;    adenosine;    bothanechol;    captopril;    cholecystokinin;    cimetidine;    dipyridamole;    dobutamine;    enalaprilat;    furosemide;    glucagon;    morphine;    pentagastrin;    phenobarbital;    vitamin B-12;   

DOI  :  

学科分类：医学（综合）

来源: Society of Nuclear Medicine

【 摘 要 】

Objective: Pharmacologic interventions play an important role in nuclear medicine by providing additional information which may help diagnose diseases, evaluate functional reserve and reduce diagnostic imaging time. However, the nonradioactive pharmaceuticals used in nuclear medicine are not without adverse effects which must be familiar to those who administer them.Methods: Although not all-encompassing, the following is a listing of the most common nonradioactive pharmaceuticals used in nuclear medicine.Results: Included are the mechanisms of action, indications, dosages and adverse effects of each agent, organized alphabetically for easy reference.Conclusions: This listing should provide an easy reference for the nuclear medicine technologist when using these pharmaceuticals.

【 授权许可】

Unknown